Pfizer, one of the world’s largest pharmaceutical companies, has announced that David Lepoittevin will be its new country manager for Belgium and Luxembourg.
Eli Lilly in Kinsale is the prime example of developments the president said the US should not have allowed to happen ...
M Company’s performance drops despite spin-off, with higher multiples than peers. See why MMM stock is considered unfavorable ...
Pharmaceutical companies are currently granted at least eight years’ “protection” over their data from research and clinical ...
BioNTech is expanding its oncology pipeline with FixVac, iNeST, and BNT327 for individualized cancer treatments. Read why I ...
Learn more about whether Recursion Pharmaceuticals, Inc. or Zai Lab Limited is a better investment based on AAII's A+ ...
Uganda is among the top 26 poor countries that are most vulnerable to the Donald Trump administration's chokehold on foreign ...
Orphan Drug Designation follows positive Phase 1 data presented at the 12th International Workshop on Waldenström MacroglobulinemiaFirst-in-class ...
CHELMSFORD, MA / ACCESS Newswire / March 17, 2025 / Harte Hanks, Inc. (NASDAQ:HHS), a leading global customer experience company focused on bringing companies closer to customers for over 100 years, t ...
Pfizer’s CEO Albert Bourla has revamped sales tactics, leading to a 31% rise in U.S. sales of Nurtec migraine medication, reports The Wall Street Journal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results